(Q30842312)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Potentiation of the therapeutic index of interleukin-2 immunotherapy by combination with taurine in a syngeneic murine tumour model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

N Finnegan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D Toomey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

H P Redmond

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Da Costa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D J Bouchier-Hayes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

Irish Journal of Medical Science

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

85-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12173896%20AND%20SRC:MED&resulttype=core&format=json

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

12 November 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03168959

An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2

21 January 2018

1 reference

12 December 2020

The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases

1 reference

12 December 2020

Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.

1 reference

12 December 2020

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

12 December 2020

Successful treatment of murine melanoma with bryostatin 1.

1 reference

12 December 2020

Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization

1 reference

12 December 2020

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

1 reference

12 December 2020

Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously

1 reference

12 December 2020

Enhanced activity against syngeneic murine tumors by intrasplenic injection of recombinant interleukin-2 (IL-2) and interleukin-1 (IL-1)

1 reference

12 December 2020

Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells

1 reference

12 December 2020

Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury

1 reference

12 December 2020

Calcium-dependent natural killer and calcium-independent natural cytotoxic activities in an IL-2-dependent killer cell line

1 reference

12 December 2020

In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice

1 reference

12 December 2020

The effect of taurine on age-related immune decline in mice: the effect of taurine on T cell and B cell proliferative response under costimulation with ionomycin and phorbol myristate acetate

1 reference

12 December 2020

Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery

1 reference

12 December 2020

Physiological actions of taurine

1 reference

12 December 2020

The beneficial effect of taurine on the prevention of human endothelial cell death

1 reference

12 December 2020

Taurine modulates chemical nociception in mice

1 reference

12 December 2020

Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth

1 reference

12 December 2020

Modulation of hematologic and immunologic effects of high dose chemotherapy by interleukin-2 in a murine tumor model

1 reference

12 December 2020

Lysis of endothelial cells by autologous lymphokine-activated killer cells.

1 reference

12 December 2020

Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis

1 reference

12 December 2020

NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium

1 reference

12 December 2020